Search Results 1511-1520 of 17047 for First%2Baid

  1. Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent ...

  2. Clinical Trials - INcrease Of VAgal TonE in CHF

    There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent ...

  3. A Study to Evaluate Entolimod on Immune System Aging in Healthy Geriatric Subjects Receiving Influenza Vaccination - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent ...

  4. A Study of the Effectiveness of Sulfasalazine in Preventing Acute Diarrhea in Patients with Cancer who are Undergoing Pelvic Radiation Therapy - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent ...

  5. A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies - Mayo Clinic

    ... first dose of study treatment. - Prior treatment with an anti-TIGIT antibody. - Any active or prior autoimmune disease that required treatment within 3 ...

  6. A Study to Evaluate the Effectiveness and Safety of bb2121 in Subjects with Relapsed and Refractory Multiple Myeloma and in Subjects with Clinical High-Risk Multiple Myeloma - Mayo Clinic

    ... early relapse. The cohorts will start in parallel and independently ... - Must have achieved documented PR or VGPR at first post-ASCT assessment

  7. A Study to Evaluate AVB-S6-500 with Paclitaxel vs Paclitaxel in Patients with Platinum-resistant Recurrent Ovarian Cancer - Mayo Clinic

    after completion of the first platinum regimen) - Is being treated with concurrent anticancer therapy or other interventional treatments administered for ...

  8. Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004) - Mayo Clinic

    ... first dose of study intervention. * Completed palliative radiotherapy within 7 days of the first dose. Participants must have recovered from all radiation ...

  9. Trigeminal neuralgia - Doctors and departments - Mayo Clinic

    Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to ...

  10. Arthritis - Doctors and departments - Mayo Clinic

    Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to ...